Top Stories

Guttify Introduces India’s First Saliva-Based At-Home Gut Health Test

Image alt text

The test provides a quick, noninvasive method for assessing gut health at home. It delivers results within 24 hours without requiring stool samples or lab visits.

Delhi-based gut health startup Guttify, a Lifechart venture, has introduced India’s first saliva-based gut scan kit priced at INR 199.

The test provides a quick, noninvasive method for assessing gut health at home. It delivers results within 24 hours without requiring stool samples or lab visits.

The Gut Scan Kit is ISO certified and NABL-accredited through Fair Labs, ensuring efficacy and safety standards. It uses advanced microbiological research techniques to detect gram-negative harmful bacteria, which are often linked to common gut issues such as bloating, constipation, acidity, and fatigue, which affect millions in India.

Upon completing the test, users receive a detailed gut health report, personalized dietary and lifestyle recommendations, and a tailored healing protocol. The kit explicitly addresses Indian biology and lifestyle factors.

Guttify has raised over $1 million in funding, including an extended seed round of $360,000 in May 2025. The new capital aims to support the scale-up of its diagnosis-first, at-home gut wellness solutions targeting urban and semi-urban Indian markets.

Mukul Shah, Co-founder of Guttify, stated, "We believe gut health is the foundation of overall well-being, yet it’s often overlooked due to the lack of accessible and accurate testing. Our saliva-based quick test makes advanced gut health diagnostics available to every Indian household."

The startup also added Prashant Pitti, founder of EaseMyTrip and Optimio, as a strategic advisor and investor. Since its launch in May 2025, Guttify has served more than 5,000 customers across India and reports a monthly growth rate between 30 and 35 percent.

More Articles By This Author


Show All
Newsletter

Signup for newsletter and stay updated

When digital health information is abundant but time is limited, access to curated, high-quality insights is more crucial than ever. Subscribe to our daily newsletter

Sign In

Sign In / Sign Up

Sign In & Stay updated with the latest news and analysis

+91